Pages that link to "Q56427239"

The following pages link to Peter Connick (Q56427239):

Displaying 18 items.

• Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis (Q28545984) (← links)
• Procedural confidence in hospital based practitioners: implications for the training and practice of doctors at all grades (Q33399271) (← links)
• The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments (Q34686955) (← links)
• Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study (Q35757641) (← links)
• Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming (Q35947718) (← links)
• Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition (Q36538815) (← links)
• Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosis. (Q37267155) (← links)
• Patterns of cognitive dysfunction in progressive MS. (Q37561350) (← links)
• Genetic epidemiology of motor neuron disease-associated variants in the Scottish population (Q37635851) (← links)
• Stem cells as a resource for regenerative neurology (Q37829160) (← links)
• Mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in amyotrophic lateral sclerosis (Q48674044) (← links)
• Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review (Q64256084) (← links)
• Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multipl (Q64450175) (← links)
• Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: a systematic review (Q64450177) (← links)
• The neuromuscular emergency consult (Q64450180) (← links)
• PATTERNS OF COGNITIVE DYSFUNCTION IN PROGRESSIVE MULTIPLE SCLEROSIS (Q64450182) (← links)
• Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis: Figure 1 (Q64450185) (← links)
• Lipid Profile Components and Risk of Ischemic Stroke: A Role for the Pleiotropic Effects of Statins (Q64450188) (← links)